Hepatic arterial infusion chemotherapy plus regorafenib compared with regorafenib alone as second-line therapy for advanced hepatocellular carcinoma: a randomised controlled trial protocol

Hepatic arterial infusion chemotherapy plus regorafenib compared with regorafenib alone as second-line therapy for advanced hepatocellular carcinoma: a randomised controlled trial protocol

Introduction The exact role of hepatic arterial infusion chemotherapy (HAIC) in advanced hepatocellular carcinoma (aHCC) is still unknown. The combination of HAIC and sorafenib has been proven to be more effective than sorafenib alone in the first-line treatment of aHCC. The aim of the study is to e...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Sun, Xiao Li, Tao Gong, He Zhao, Xiaowu Zhang, Pengfei Tian, Yingen Luo, Jingui Li, Zhengqiang Yang, Peng Song
Format: Article
Language:English
Published: BMJ Publishing Group 2024-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/12/e080805.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items